GW Pharma (GWPH) Epidiolex Beats High Expectations, PT to $210 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst Danielle Brill raised the price target on GW Pharma (NASDAQ: GWPH) to $210.00 (from $185.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
